<--- Back to Details
First PageDocument Content
Psychedelics /  dissociatives and deliriants / Alcohols / Drug Enforcement Administration / Decongestants / Narcotic / Convention on Psychotropic Substances / Controlled Substances Act / Designer drug / Single Convention on Narcotic Drugs / Chemistry / Euphoriants / Pharmacology
Date: 2013-10-29 08:28:49
Psychedelics
dissociatives and deliriants
Alcohols
Drug Enforcement Administration
Decongestants
Narcotic
Convention on Psychotropic Substances
Controlled Substances Act
Designer drug
Single Convention on Narcotic Drugs
Chemistry
Euphoriants
Pharmacology

Controlled Substances Act

Add to Reading List

Source URL: www.naabt.org

Download Document from Source Website

File Size: 510,47 KB

Share Document on Facebook

Similar Documents

FLUBROMAZEPAM Stephanie Hopkins, California Department of Justice, 4949 Broadway, Room F-249, Sacramento CA, Manufacturer: A “designer” drug. First described in 1962 by Sternbach (

DocID: 1u7eJ - View Document

FLUBROMAZEPAM Stephanie Hopkins, California Department of Justice, 4949 Broadway, Room F-249, Sacramento CA, Manufacturer: A “designer” drug. First described in 1962 by Sternbach (

DocID: 1u2MR - View Document

Ekctmchimica Acta,Vol.39.No. 4.ppCopyri&tt Q 1994 Elsevier Scicna Ltd. Printed inGreatBritainAU rights mewed

DocID: 1sNHy - View Document

LETTER 555 A Simple Protocol for Direct Reductive Amination of Aldehydes and Ketones Using Potassium Formate and Catalytic Palladium Acetate

DocID: 1stBf - View Document

TETRAHEDRON Pergamon Tetrahedron±5674 A modi®ed palladium catalysed reductive amination procedure

DocID: 1rDwT - View Document